including a minimum of $30 million in cash and $20 million in PTX common stock (based on the closing price on March 9, 2015). Under the agreement, Pernix will issue to Zogenix a 6 month $50 million promissory note which accrues …
He says this suit could crash the stock. He wants me to buy 20,000 shares of Zogenix with the money from the sale of Merck. Zogenix is a small specialty drug company. His research department believes that it has a sensational …
Drugmaker Zogenix said Wednesday that a drug once used to fight obesity before it was taken off the market may help treat a rare disease that causes severe seizures in young children ... of Vivus Inc.'s anti-obesity drug Qsymia. Dravet …
around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. ZGNX closed Tuesday's trading at $1.67, down 2.34%. In after-hours, the stock was down 9.58% at $1.51.
Zogenix (NASDAQ: ZGNX) recently announced positive results ... which in turn would dampen investors' enthusiasm about the stock. Around 85% of drugs that are submitted to the FDA ultimately win approval. My take is that …
SAN DIEGO, April 12, 2011 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) today announced the establishment of a Named Patient Program for SUMAVEL ® DosePro ® (sumatriptan injection) Needle-free Delivery System. A …
Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, announced today that James B. Breitmeyer, M.D., …
Zogenix, Inc. (Nasdaq: ZGNX) announced that it has been informed today by the U.S. Food and Drug Administration (FDA) that an action letter on the New Drug Application (NDA) for Zohydro ER (hydrocodone bitartrate) extended …
SAN DIEGO and HAMBURG, Germany, Dec. 2, 2010 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) and …
Zogenix, Inc. (Nasdaq: ZGNX) announced the appointment of R. Scott Shively to serve as executive vice president and chief commercial officer. Scott previously served as vice president - global commercial disease area lead for pain for …